SLNO Meredith Manning sells $239K worth of shares
Apr 01, 2026, 4:35 AM
0.00%
What does SLNO do
Soleno Therapeutics, a clinical-stage biopharmaceutical company based in Redwood City, California, focuses on developing novel therapeutics for rare diseases, notably DCCR for Prader-Willi syndrome. DCCR, a once-daily oral tablet, recently completed Phase 3 trials and has received Fast-Track and orphan designations in the U.S. and EU.
Meredith Manning sold 7,522 shares of SLNO on 27 March at $31.72 per share, worth a total of $239K. They now own 67,165 SLNO shares, or a 10% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.